APA (7th ed.) Citation

Ngernsombat, C., Suriya, U., Prattapong, P., Verma, K., Rungrotmongkol, T., Soonkum, T., . . . Janvilisri, T. Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: Insights from molecular dynamics simulations and experimental validation. Nature Portfolio.

Chicago Style (17th ed.) Citation

Ngernsombat, Chawalit, Utid Suriya, Pongphol Prattapong, Kanika Verma, Thanyada Rungrotmongkol, Thananya Soonkum, Sakonwan Kuhaudomlarp, and Tavan Janvilisri. Repurposing FDA-approved Drugs Targeting FZD10 in Nasopharyngeal Carcinoma: Insights from Molecular Dynamics Simulations and Experimental Validation. Nature Portfolio.

MLA (9th ed.) Citation

Ngernsombat, Chawalit, et al. Repurposing FDA-approved Drugs Targeting FZD10 in Nasopharyngeal Carcinoma: Insights from Molecular Dynamics Simulations and Experimental Validation. Nature Portfolio.